Shares of Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) were down 27.6% during mid-day trading on Thursday . The company traded as low as $0.38 and last traded at $0.40. Approximately 5,005 shares were traded during mid-day trading, an increase of 244% from the average daily volume of 1,454 shares. The stock had previously closed at $0.55.
Zelira Therapeutics Stock Up 10.6 %
The stock has a 50 day simple moving average of $0.35 and a 200-day simple moving average of $0.47.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Further Reading
- Five stocks we like better than Zelira Therapeutics
- Consumer Staples Stocks, Explained
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- What is a buyback in stocks? A comprehensive guide for investors
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
